Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search
4 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Riddle me this: Which tRump family members and/or supporters are invested in the production of (Original Post) Floyd R. Turbo Apr 2020 OP
Never pay a bribe to the king. safeinOhio Apr 2020 #1
give this a read if you'd like IcyPeas Apr 2020 #2
Just blatant sales pitch from the bully puppet. stillcool Apr 2020 #4
I like Jarad.. stillcool Apr 2020 #3

IcyPeas

(21,865 posts)
2. give this a read if you'd like
Mon Apr 6, 2020, 09:30 PM
Apr 2020
https://readsludge.com/2020/04/06/pharma-funded-group-run-by-a-top-trump-donor-is-promoting-malaria-drug-to-the-president/

...hydroxychloroquine, but one answer may lie with the millions of dollars in political support he has received from the founder of a pharmaceutical industry-funded group that has been pushing him to make the drug available.

... calling on Trump to “cut the red tape” and immediately make hydroxychloroquine available to treat patients.

The Job Creators Network was founded in 2011 by billionaire Home Depot co-founder Bernard Marcus, a major GOP donor who spent more than $7 million through outside groups to help elect Trump in 2016. Marcus has said that he plans to spend part of his fortune to help re-elect Trump in 2020.

Job Creators Network has been funded by Pharmaceutical Research and Manufacturers of America (PhRMA), a drug industry trade that counts among its members leading hydroxychloroquine makers Novartis, Teva Pharmaceuticals, and Bayer. According to tax documents, PhRMA donated $500,000 to Job Creators Network in 2017.

Novartis, Teva, and Bayer have all committed to providing millions of doses of hydroxychloroquine for clinical testing, and the companies potentially stand to profit if the drug becomes adopted as a common coronavirus treatment.
Latest Discussions»General Discussion»Riddle me this: Which tRu...